Narodni Ustav Dusevniho Zdravi — Clinical Trial Site

10 Registered trials

4 Currently recruiting

Organisation

Narodni Ustav Dusevniho Zdravi

Location

Klecany, Czechia

Identifier

ORG-100044300

Address

Topolova 748, 250 67, Czechia

Departments

Clinic
Clinic Contract Research Department
N/A
Narodni ustav dusevniho zdravi
Oddělení poruch spánku
Psychedelic research centre
Psychiatry
Výzkumné centrum NUDZ

Clinical trials at this site (10)

Search interface

Evenamide in patients with treatment-resistant schizophrenia not responding to antipsychotics Recruiting

2024-519836-18-00 treatment-resistant schizophrenia (TRS) 5 2025-12-16
Long-term study to assess the safety and tolerability of adjunctive NBI-1065845 in adults with Major Depressive Disorder (MDD) Recruiting

2024-519423-24-00 Major Depressive Disorder 5 2025-10-07
PsyPal; Psilocybin Therapy for Psychological Distress in Palliative Patients Recruiting

2023-510488-36-01 Chronic obstructive pulmonary disease (COPD), amyotroph 4 2025-06-01
Psilocybin - a strategy of rapid antidepressant response in depression comorbid with cancer,a randomized double-blind study with the possib… Recruiting

2024-517747-31-00 Depressive disorder comorbid with cancer 4 2022-07-22
Antidepressant effects of psilocybin in pharmaco-resistant depression Ended

2024-515899-13-00 pharmaco-resistant depression 4 2024-11-21
A Phase III study to investigate two initial administrations of COMP360 in treatment-resistant depression Ended

2023-505268-12-00 Treatment-resistant depression 5 2024-02-09
A study to learn about how elinzanetant works and how safe it is in women having sleep disturbances associated with menopause Ended

2023-504955-28-01 Sleep disturbances associated with menopause 4 2024-03-14
A study to evaluate if aticaprant added to a current antidepressant and given up to one year is safe and would help improve depression. Ended

2023-508163-74-00 Major Depressive Disorder 5 2023-06-12
Protocol Lay Person Short Title: A Trial of the Safety and Efficacy of Flexible Doses of SEP-363856 as Adjunctive Therapy in the Treatment o… Ended

2022-500538-27-00 Adjunctive therapy to antidepressants for the treatmen 10 2023-03-30
A study to test long-term safety of Iclepertin in people with schizophrenia who took part in a previous CONNEX study Ended

2024-511560-93-00 Schizophrenia 5 2022-03-29